Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Urology
|
January 8, 2013
Long-term efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: an interim analysis
Michael Kennelly, Roger Dmochowski, Karen Ethans, et al.
The Journal of Spinal Cord Medicine
|
August 29, 2012
International standards to document remaining autonomic function after spinal cord injury
Andrei Krassioukov, Fin Biering-Sørensen, William Donovan, et al.
Advances in Urology
|
May 9, 2019
Adult Neurogenic Lower Urinary Tract Dysfunction and Intermittent Catheterisation in a Community Setting: Risk Factors Model for Urinary Tract Infections
Michael Kennelly, Nikesh Thiruchelvam, Márcio Augusto Averbeck, et al.
Current Medical Research and Opinion
|
February 21, 2018
Clean intermittent catheterization rates after initial and subsequent treatments with onabotulinumtoxinA for non-neurogenic overactive bladder in real-world clinical settings
Michael Kennelly, Lonny Green, Nancy Alvandi, et al.
Journal of Neurotrauma
|
November 8, 2017
Intermittent Catheterization: The Devil Is in the Details
Kathleen Christison, Matthias Walter, Jean-Jacques J M Wyndaele, et al.
Neurourology and Urodynamics
|
November 27, 2015
Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study
Michael Kennelly, Roger Dmochowski, Heinrich Schulte-Baukloh, et al.
British Journal of Nursing (Mark Allen Publishing)
|
October 13, 2023
Risk factors for urinary tract infections associated with lower quality of life among intermittent catheter users
Marcio Augusto Averbeck, Michael Kennelly, Nikesh Thiruchelvam, et al.
International Journal of Clinical Practice
|
June 10, 2022
Vibegron for the Treatment of Patients with Dry and Wet Overactive Bladder: A Subgroup Analysis from the EMPOWUR Trial
David Staskin, Jeffrey Frankel, Susann Varano, et al.
The Journal of Spinal Cord Medicine
|
March 3, 2004
Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial
Jang Hwan Kim, David A Rivas, Patrick J Shenot, et al.
Spine
|
April 2, 2008
Vardenafil improves ejaculation success rates and self-confidence in men with erectile dysfunction due to spinal cord injury
Francois Giuliano, Eusebio Rubio-Aurioles, Michael Kennelly, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Urology
|
January 8, 2013
Long-term efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: an interim analysis
Michael Kennelly, Roger Dmochowski, Karen Ethans, et al.
The Journal of Spinal Cord Medicine
|
August 29, 2012
International standards to document remaining autonomic function after spinal cord injury
Andrei Krassioukov, Fin Biering-Sørensen, William Donovan, et al.
Advances in Urology
|
May 9, 2019
Adult Neurogenic Lower Urinary Tract Dysfunction and Intermittent Catheterisation in a Community Setting: Risk Factors Model for Urinary Tract Infections
Michael Kennelly, Nikesh Thiruchelvam, Márcio Augusto Averbeck, et al.
Current Medical Research and Opinion
|
February 21, 2018
Clean intermittent catheterization rates after initial and subsequent treatments with onabotulinumtoxinA for non-neurogenic overactive bladder in real-world clinical settings
Michael Kennelly, Lonny Green, Nancy Alvandi, et al.
Journal of Neurotrauma
|
November 8, 2017
Intermittent Catheterization: The Devil Is in the Details
Kathleen Christison, Matthias Walter, Jean-Jacques J M Wyndaele, et al.
Neurourology and Urodynamics
|
November 27, 2015
Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study
Michael Kennelly, Roger Dmochowski, Heinrich Schulte-Baukloh, et al.
British Journal of Nursing (Mark Allen Publishing)
|
October 13, 2023
Risk factors for urinary tract infections associated with lower quality of life among intermittent catheter users
Marcio Augusto Averbeck, Michael Kennelly, Nikesh Thiruchelvam, et al.
International Journal of Clinical Practice
|
June 10, 2022
Vibegron for the Treatment of Patients with Dry and Wet Overactive Bladder: A Subgroup Analysis from the EMPOWUR Trial
David Staskin, Jeffrey Frankel, Susann Varano, et al.
The Journal of Spinal Cord Medicine
|
March 3, 2004
Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial
Jang Hwan Kim, David A Rivas, Patrick J Shenot, et al.
Spine
|
April 2, 2008
Vardenafil improves ejaculation success rates and self-confidence in men with erectile dysfunction due to spinal cord injury
Francois Giuliano, Eusebio Rubio-Aurioles, Michael Kennelly, et al.
Page
of 4